MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 16, 2024 | Sale | $59.02 | 1,597 | 94,255 | 117,659 | Jan 18, 2024, 04:45 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP & Chief Scientific Officer | Jan 16, 2024 | Sale | $59.02 | 1,597 | 94,255 | 156,558 | Jan 18, 2024, 04:38 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 08, 2024 | Sale | $58.92 | 2,090 | 123,143 | 118,625 | Jan 09, 2024, 05:54 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP & Chief Scientific Officer | Jan 04, 2024 | Sale | $58.81 | 1,531 | 90,038 | 157,135 | Jan 05, 2024, 05:34 PM |
MRTX | | Mirati Therapeutics, Inc. | Davis Aaron I. | Director | Dec 29, 2023 | Option Exercise | $58.75 | 6,808 | 399,970 | 54,325 | Jan 03, 2024, 08:50 PM |
MRTX | | Mirati Therapeutics, Inc. | Johnson Craig A | Director | Dec 29, 2023 | Option Exercise | $58.75 | 6,808 | 399,970 | 17,273 | Jan 03, 2024, 06:37 PM |
MRTX | | Mirati Therapeutics, Inc. | Martinez Maria E | Director | Dec 29, 2023 | Option Exercise | $58.75 | 6,808 | 399,970 | 17,273 | Jan 03, 2024, 06:32 PM |
MRTX | | Mirati Therapeutics, Inc. | Gallagher Carol Giltner | Director | Dec 29, 2023 | Option Exercise | $58.75 | 6,808 | 399,970 | 14,363 | Jan 03, 2024, 06:27 PM |
MRTX | | Mirati Therapeutics, Inc. | Sharp Shalini | Director | Dec 29, 2023 | Option Exercise | $58.75 | 6,808 | 399,970 | 16,222 | Jan 03, 2024, 06:24 PM |
MRTX | | Mirati Therapeutics, Inc. | Cherrington Julie M | Director | Dec 29, 2023 | Option Exercise | $58.75 | 6,808 | 399,970 | 11,252 | Jan 03, 2024, 06:22 PM |
MRTX | | Mirati Therapeutics, Inc. | Hasnain Faheem | Director | Dec 29, 2023 | Option Exercise | $58.75 | 9,702 | 569,993 | 24,752 | Jan 03, 2024, 06:18 PM |
MRTX | | Mirati Therapeutics, Inc. | CARTER BRUCE L A | Director | Dec 29, 2023 | Option Exercise | $58.75 | 6,808 | 399,970 | 17,273 | Jan 03, 2024, 06:16 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Dec 29, 2023 | Option Exercise | $58.75 | 17,021 | 999,984 | 120,715 | Jan 03, 2024, 06:13 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP & Chief Scientific Officer | Dec 29, 2023 | Option Exercise | $58.75 | 17,021 | 999,984 | 158,666 | Jan 03, 2024, 06:05 PM |
MRTX | | Mirati Therapeutics, Inc. | Sandler Alan B. | Chief Medical Officer | Dec 29, 2023 | Option Exercise | $58.75 | 17,021 | 999,984 | 79,318 | Jan 03, 2024, 06:01 PM |
MRTX | | Mirati Therapeutics, Inc. | Ondrey Aaron | CFO | Dec 29, 2023 | Option Exercise | $58.75 | 17,021 | 999,984 | 39,461 | Jan 03, 2024, 05:55 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | Interim CEO | Dec 29, 2023 | Option Exercise | $58.75 | 20,425 | 1,199,969 | 247,700 | Jan 03, 2024, 05:52 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP & Chief Scientific Officer | Dec 18, 2023 | Sale | $57.50 | 2,387 | 137,253 | 141,645 | Dec 19, 2023, 04:59 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Dec 13, 2023 | Sale | $56.67 | 2,220 | 125,807 | 103,694 | Dec 14, 2023, 05:05 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP & Chief Scientific Officer | Sep 08, 2023 | Sale | $35.63 | 2,388 | 85,084 | 144,032 | Sep 12, 2023, 05:41 PM |
MRTX | | Mirati Therapeutics, Inc. | Ondrey Aaron | Interim CFO | Sep 08, 2023 | Option Exercise | $35.66 | 8,412 | 299,972 | 22,440 | Sep 12, 2023, 05:30 PM |
MRTX | | Mirati Therapeutics, Inc. | Fuglesang Christopher | See remarks | Aug 11, 2023 | Buy | $27.80 | 1,201,440 | 33,400,031 | 3,201,440 | Aug 15, 2023, 09:39 PM |
MRTX | | Mirati Therapeutics, Inc. | Davis Aaron I. | See remarks | Aug 11, 2023 | Buy | $27.80 | 57,533 | 1,599,417 | 287,866 | Aug 15, 2023, 09:39 PM |
MRTX | | Mirati Therapeutics, Inc. | Dissanayake Shehan Bharatha | See remarks | Aug 11, 2023 | Buy | $27.80 | 1,201,440 | 33,400,031 | 3,201,440 | Aug 15, 2023, 09:38 PM |
MRTX | | Mirati Therapeutics, Inc. | Dissanayake Shehan Bharatha | See remarks | Aug 11, 2023 | Buy | $27.80 | 57,533 | 1,599,417 | 287,866 | Aug 15, 2023, 09:38 PM |
MRTX | | Mirati Therapeutics, Inc. | Hasnain Faheem | Director | Aug 11, 2023 | Buy | $27.80 | 10,791 | 299,990 | 10,791 | Aug 14, 2023, 04:41 PM |
MRTX | | Mirati Therapeutics, Inc. | Stelzer Laurie | Chief Financial Officer | Aug 09, 2023 | Option Exercise | $37.00 | 22,297 | 824,989 | 102,312 | Aug 10, 2023, 04:26 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | Interim CEO | Aug 09, 2023 | Option Exercise | $37.00 | 54,054 | 1,999,998 | 227,275 | Aug 10, 2023, 04:24 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Aug 09, 2023 | Option Exercise | $37.00 | 22,297 | 824,989 | 105,914 | Aug 10, 2023, 04:23 PM |
MRTX | | Mirati Therapeutics, Inc. | Moriarty John B | Chief Legal Officer | Aug 09, 2023 | Option Exercise | $37.00 | 22,297 | 824,989 | 71,660 | Aug 10, 2023, 04:22 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP & Chief Scientific Officer | Aug 09, 2023 | Option Exercise | $37.00 | 22,297 | 824,989 | 146,420 | Aug 10, 2023, 04:21 PM |
MRTX | | Mirati Therapeutics, Inc. | Sandler Alan B. | Chief Medical Officer | Aug 09, 2023 | Option Exercise | $37.00 | 22,297 | 824,989 | 62,297 | Aug 10, 2023, 04:19 PM |
MRTX | | Mirati Therapeutics, Inc. | Stelzer Laurie | Chief Financial Officer | Jun 02, 2023 | Sale | $37.06 | 4,647 | 172,218 | 80,015 | Jun 02, 2023, 07:15 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP & Chief Scientific Officer | May 24, 2023 | Sale | $45.29 | 619 | 28,035 | 124,123 | May 24, 2023, 07:38 PM |
MRTX | | Mirati Therapeutics, Inc. | Cherrington Julie M | Director | Jan 18, 2023 | Sale | $44.66 | 2,546 | 113,704 | 0 | Jan 20, 2023, 09:20 AM |
MRTX | | Mirati Therapeutics, Inc. | Meek David D. | Chief Executive Officer | Jan 17, 2023 | Sale | $42.38 | 3,179 | 134,715 | 61,792 | Jan 19, 2023, 09:45 AM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Jan 17, 2023 | Sale | $42.38 | 2,245 | 95,142 | 98,765 | Jan 19, 2023, 09:45 AM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 17, 2023 | Sale | $42.38 | 1,566 | 66,366 | 47,842 | Jan 19, 2023, 09:45 AM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 09, 2023 | Sale | $45.37 | 2,088 | 94,733 | 48,789 | Jan 10, 2023, 05:00 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President,Founder,Head of R&D | Jan 04, 2023 | Sale | $46.60 | 3,648 | 169,997 | 168,777 | Jan 05, 2023, 05:13 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Jan 04, 2023 | Sale | $46.60 | 1,949 | 90,823 | 100,123 | Jan 05, 2023, 05:13 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President,Founder,Head of R&D | Dec 21, 2022 | Sale | $40.42 | 9,092 | 367,469 | 172,425 | Dec 21, 2022, 09:21 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Dec 21, 2022 | Sale | $40.41 | 3,248 | 131,266 | 50,877 | Dec 21, 2022, 09:20 PM |
MRTX | | Mirati Therapeutics, Inc. | Meek David D. | Chief Executive Officer | Dec 21, 2022 | Sale | $40.41 | 4,616 | 186,552 | 64,971 | Dec 21, 2022, 09:20 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Dec 16, 2022 | Sale | $43.00 | 2,410 | 103,624 | 102,072 | Dec 20, 2022, 04:02 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Dec 02, 2022 | Sale | $90.19 | 1,726 | 155,667 | 104,482 | Dec 05, 2022, 05:00 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President,Founder,Head of R&D | Nov 28, 2022 | Option Exercise | $58.70 | 138,512 | 8,131,347 | 197,155 | Nov 28, 2022, 07:01 PM |
MRTX | | Mirati Therapeutics, Inc. | CARTER BRUCE L A | Director | Aug 12, 2022 | Sale | $56.24 | 20,000 | 1,124,899 | 16,021 | Aug 16, 2022, 04:15 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | May 23, 2022 | Sale | $63.54 | 624 | 39,649 | 86,804 | Jun 14, 2022, 04:35 PM |
MRTX | | Mirati Therapeutics, Inc. | Cherrington Julie M | Director | Jan 19, 2022 | Sale | $116.07 | 1,475 | 171,203 | 2,546 | Jan 20, 2022, 04:57 PM |
MRTX | | Mirati Therapeutics, Inc. | REED VICKIE S | SVP, Chief Accounting Officer | Jan 18, 2022 | Sale | $120.48 | 533 | 64,217 | 15,369 | Jan 18, 2022, 08:34 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Jan 18, 2022 | Sale | $120.51 | 627 | 75,558 | 87,428 | Jan 18, 2022, 08:33 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President,Founder,Head of R&D | Jan 18, 2022 | Sale | $64.83 | 6,220 | 403,234 | 130,416 | Jan 18, 2022, 08:32 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 18, 2022 | Sale | $120.48 | 627 | 75,543 | 34,976 | Jan 18, 2022, 08:32 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 07, 2022 | Sale | $135.94 | 1,964 | 266,984 | 24,848 | Jan 07, 2022, 08:27 PM |
MRTX | | Mirati Therapeutics, Inc. | REED VICKIE S | SVP, Chief Accounting Officer | Jan 07, 2022 | Sale | $135.94 | 345 | 46,900 | 10,525 | Jan 07, 2022, 08:26 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President,Founder,Head of R&D | Jan 04, 2022 | Sale | $147.75 | 4,114 | 607,855 | 101,239 | Jan 06, 2022, 04:51 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Jan 04, 2022 | Sale | $147.72 | 1,442 | 213,017 | 77,300 | Jan 06, 2022, 04:51 PM |
MRTX | | Mirati Therapeutics, Inc. | REED VICKIE S | SVP, Chief Accounting Officer | Jan 04, 2022 | Sale | $147.74 | 758 | 111,987 | 10,870 | Jan 06, 2022, 04:50 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Dec 06, 2021 | Sale | $130.79 | 1,201 | 157,078 | 59,514 | Dec 07, 2021, 05:52 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & Head of R&D | Dec 03, 2021 | Sale | $70.85 | 94,408 | 6,688,456 | 159,918 | Dec 03, 2021, 08:09 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | May 24, 2021 | Sale | $154.34 | 435 | 67,138 | 53,850 | May 25, 2021, 06:04 PM |
MRTX | | Mirati Therapeutics, Inc. | CARTER BRUCE L A | Director | Apr 05, 2021 | Sale | $91.95 | 4,500 | 413,763 | 5,725 | Apr 06, 2021, 08:06 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Mar 19, 2021 | Sale | $145.38 | 4,738 | 688,826 | 29,181 | Mar 22, 2021, 04:42 PM |
MRTX | | Mirati Therapeutics, Inc. | LEWIS JOSEPH | 10% Owner | Mar 09, 2021 | Sale | $98.83 | 23,942 | 2,366,264 | 3,135,967 | Mar 10, 2021, 09:30 PM |
MRTX | | Mirati Therapeutics, Inc. | LEWIS JOSEPH | 10% Owner | Mar 10, 2021 | Sale | $98.38 | 820 | 80,672 | 3,135,967 | Mar 10, 2021, 09:30 PM |
MRTX | | Mirati Therapeutics, Inc. | Boxer Asset Management Inc. | 10% Owner | Mar 05, 2021 | Option Exercise | $71.64 | 1,011,445 | 72,461,514 | 2,363,004 | Mar 09, 2021, 09:48 PM |
MRTX | | Mirati Therapeutics, Inc. | Cherrington Julie M | Director | Mar 02, 2021 | Sale | $201.01 | 2,000 | 402,020 | 1,485 | Mar 04, 2021, 05:25 PM |
MRTX | | Mirati Therapeutics, Inc. | Faga Daniel | EVP, Chief Operating Officer | Feb 02, 2021 | Option Exercise | $154.36 | 2,680 | 413,671 | 31,978 | Feb 03, 2021, 05:09 PM |
MRTX | | Mirati Therapeutics, Inc. | CARTER BRUCE L A | Director | Feb 02, 2021 | Sale | $98.95 | 4,500 | 445,272 | 5,725 | Feb 03, 2021, 05:08 PM |
MRTX | | Mirati Therapeutics, Inc. | Martinez Maria E | Director | Jan 29, 2021 | Sale | $121.65 | 15,000 | 1,824,784 | 10,975 | Feb 01, 2021, 09:47 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Jan 26, 2021 | Option Exercise | $5.40 | 2,292 | 12,377 | 112,714 | Jan 28, 2021, 05:45 PM |
MRTX | | Mirati Therapeutics, Inc. | Johnson Craig A | Director | Jan 21, 2021 | Sale | $116.04 | 30,000 | 3,481,307 | 18,475 | Jan 25, 2021, 04:31 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Jan 19, 2021 | Option Exercise | $27.00 | 3,245 | 87,615 | 110,422 | Jan 20, 2021, 06:17 PM |
MRTX | | Mirati Therapeutics, Inc. | REED VICKIE S | SVP, Chief Accounting Officer | Jan 06, 2021 | Sale | $210.39 | 538 | 113,190 | 8,239 | Jan 08, 2021, 07:57 PM |
MRTX | | Mirati Therapeutics, Inc. | REED VICKIE S | SVP, Chief Accounting Officer | Jan 07, 2021 | Sale | $216.33 | 241 | 52,135 | 7,471 | Jan 08, 2021, 07:57 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 07, 2021 | Sale | $216.33 | 2,078 | 449,525 | 21,858 | Jan 08, 2021, 07:46 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Jan 06, 2021 | Sale | $210.39 | 1,459 | 306,961 | 48,692 | Jan 08, 2021, 07:15 PM |
MRTX | | Mirati Therapeutics, Inc. | Faga Daniel | EVP, Chief Operating Officer | Jan 07, 2021 | Sale | $216.33 | 2,625 | 567,854 | 26,228 | Jan 08, 2021, 07:15 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Jan 06, 2021 | Sale | $210.39 | 4,511 | 949,066 | 91,933 | Jan 08, 2021, 07:14 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Dec 18, 2020 | Sale | $121.48 | 80,000 | 9,718,720 | 142,023 | Dec 21, 2020, 06:28 PM |
MRTX | | Mirati Therapeutics, Inc. | FUCHS HENRY J | Director | Dec 15, 2020 | Sale | $126.97 | 20,000 | 2,539,308 | 12,000 | Dec 16, 2020, 05:37 PM |
MRTX | | Mirati Therapeutics, Inc. | CARTER BRUCE L A | Director | Dec 14, 2020 | Sale | $126.53 | 4,500 | 569,381 | 4,250 | Dec 16, 2020, 05:37 PM |
MRTX | | Mirati Therapeutics, Inc. | GREY MICHAEL G | Director | Dec 14, 2020 | Sale | $131.14 | 21,800 | 2,858,900 | 15,156 | Dec 16, 2020, 05:36 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Nov 02, 2020 | Option Exercise | $8.32 | 10,879 | 90,493 | 48,721 | Nov 04, 2020, 05:59 PM |
MRTX | | Mirati Therapeutics, Inc. | Boxer Asset Management Inc. | 10% Owner | Oct 30, 2020 | Option Exercise | $101.00 | 800,006 | 80,801,060 | 1,765,562 | Oct 30, 2020, 09:54 PM |
MRTX | | Mirati Therapeutics, Inc. | Braslyn Ltd. | 10% Owner | Oct 28, 2020 | Sale | $103.28 | 590,876 | 61,028,261 | 3,135,968 | Oct 30, 2020, 09:53 PM |
MRTX | | Mirati Therapeutics, Inc. | LEWIS JOSEPH | 10% Owner | Oct 29, 2020 | Sale | $106.67 | 209,130 | 22,307,200 | 3,135,967 | Oct 30, 2020, 09:53 PM |
MRTX | | Mirati Therapeutics, Inc. | CARTER BRUCE L A | Director | Aug 11, 2020 | Sale | $66.60 | 4,500 | 299,683 | 4,250 | Aug 13, 2020, 04:03 PM |
MRTX | | Mirati Therapeutics, Inc. | FUCHS HENRY J | Director | Aug 10, 2020 | Sale | $75.96 | 20,000 | 1,519,182 | 12,000 | Aug 11, 2020, 05:36 PM |
MRTX | | Mirati Therapeutics, Inc. | Braslyn Ltd. | 10% Owner | Jun 12, 2020 | Option Exercise | $48.50 | 1,200,012 | 58,201,204 | 3,135,972 | Jun 16, 2020, 07:09 PM |
MRTX | | Mirati Therapeutics, Inc. | Braslyn Ltd. | 10% Owner | Jun 12, 2020 | Sale | $34.50 | 1,200,012 | 41,401,037 | 3,135,972 | Jun 16, 2020, 05:03 PM |
MRTX | | Mirati Therapeutics, Inc. | CARTER BRUCE L A | Director | May 18, 2020 | Option Exercise | $56.82 | 8,000 | 454,560 | 6,000 | May 20, 2020, 05:10 PM |
MRTX | | Mirati Therapeutics, Inc. | CHEN ISAN | EVP, Chief Medical Officer | May 11, 2020 | Option Exercise | $64.99 | 66,668 | 4,333,087 | 72,735 | May 13, 2020, 04:18 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Apr 27, 2020 | Option Exercise | $5.40 | 557 | 3,008 | 107,023 | Apr 28, 2020, 08:49 PM |
MRTX | | Mirati Therapeutics, Inc. | Johnson Craig A | Director | Apr 20, 2020 | Sale | $59.42 | 30,000 | 1,782,600 | 17,000 | Apr 21, 2020, 05:26 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Apr 17, 2020 | Sale | $49.41 | 80,000 | 3,952,709 | 146,466 | Apr 20, 2020, 04:59 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Mar 27, 2020 | Option Exercise | $5.40 | 2,291 | 12,371 | 106,466 | Mar 30, 2020, 05:52 PM |
MRTX | | Mirati Therapeutics, Inc. | Christensen Jamie | EVP, Chief Scientific Officer | Mar 26, 2020 | Option Exercise | $15.51 | 8,058 | 124,983 | 32,842 | Mar 27, 2020, 05:37 PM |
MRTX | | Mirati Therapeutics, Inc. | BAUM CHARLES M | President & CEO | Feb 28, 2020 | Option Exercise | $5.40 | 2,291 | 12,371 | 104,175 | Mar 02, 2020, 04:28 PM |